Earnings Scheduled For May 9, 2022
Companies Reporting Before The Bell
• Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.
HC Wainwright & Co. Initiates Coverage On Syndax Pharmaceuticals with Buy Rating, Announces Price Target of $31
HC Wainwright & Co. analyst Edward White initiates coverage on Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy rating and announces Price Target of $31.
Recap: Syndax Pharmaceuticals Q4 Earnings
Syndax Pharmaceuticals (NASDAQ:SNDX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Syndax Pharma Offers Added Data Showing ‘Continued Robust Clinical Activity with Durable Responses in Phase 1 Portion of AUGMENT-101 Trial of SNDX-5613’
- 55% overall response rate and 24% CR/CRh rate in relapsed/refractory acute leukemia patients with NPM1 or MLLr mutations; no discontinuations due to treatment-related adverse events -
- CR/CRh rates of 23% and 24% in
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Earnings Preview For Syndax Pharmaceuticals
Syndax Pharmaceuticals (NASDAQ:SNDX) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement.
Analysts estimate that Syndax Pharmaceuticals will likely report an Earnings Per Share (EPS) of $-0.23